To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia

Summary

The study is designed as a classic, randomized, double blind, placebo controlled, parallel group study including one active dose of PU AD and matching placebo, designed to assess safety, tolerability and pharmacological effects of oral PU AD (dihydrochloride salt) in subjects with mild AD

Timeline

Start

2020-06-30

Primary completion

2020-09-09

Completion

2022-11-15

Outcome

Outcome not reported

Stopped: “Samus Therapeutics company closure”

Drugs

Indications